Class information for:
Level 1: NSAIDS//COXIBS//ROFECOXIB

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
471 3340 37.5 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
648 12828 NSAIDS//NABUMETONE//ROFECOXIB

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NSAIDS Author keyword 46 14% 9% 293
2 COXIBS Author keyword 36 44% 2% 62
3 ROFECOXIB Author keyword 30 25% 3% 106
4 COX 2 INHIBITORS Author keyword 30 27% 3% 95
5 LOW DOSE ASPIRIN Author keyword 27 34% 2% 64
6 COX 2 SELECTIVE INHIBITORS Author keyword 26 61% 1% 28
7 NONSTEROIDAL ANTIINFLAMMATORY DRUGS Author keyword 25 19% 3% 116
8 CYCLO OXYGENASE 2 INHIBITORS Author keyword 20 33% 2% 51
9 GASTROPROTECTIVE AGENTS Author keyword 19 80% 0% 12
10 LUMIRACOXIB Author keyword 19 46% 1% 31

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 NSAIDS 46 14% 9% 293 Search NSAIDS Search NSAIDS
2 COXIBS 36 44% 2% 62 Search COXIBS Search COXIBS
3 ROFECOXIB 30 25% 3% 106 Search ROFECOXIB Search ROFECOXIB
4 COX 2 INHIBITORS 30 27% 3% 95 Search COX+2+INHIBITORS Search COX+2+INHIBITORS
5 LOW DOSE ASPIRIN 27 34% 2% 64 Search LOW+DOSE+ASPIRIN Search LOW+DOSE+ASPIRIN
6 COX 2 SELECTIVE INHIBITORS 26 61% 1% 28 Search COX+2+SELECTIVE+INHIBITORS Search COX+2+SELECTIVE+INHIBITORS
7 NONSTEROIDAL ANTIINFLAMMATORY DRUGS 25 19% 3% 116 Search NONSTEROIDAL+ANTIINFLAMMATORY+DRUGS Search NONSTEROIDAL+ANTIINFLAMMATORY+DRUGS
8 CYCLO OXYGENASE 2 INHIBITORS 20 33% 2% 51 Search CYCLO+OXYGENASE+2+INHIBITORS Search CYCLO+OXYGENASE+2+INHIBITORS
9 GASTROPROTECTIVE AGENTS 19 80% 0% 12 Search GASTROPROTECTIVE+AGENTS Search GASTROPROTECTIVE+AGENTS
10 LUMIRACOXIB 19 46% 1% 31 Search LUMIRACOXIB Search LUMIRACOXIB

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 NONSTEROIDAL ANTIINFLAMMATORY DRUGS 186 11% 48% 1601
2 GASTROINTESTINAL TOXICITY 182 35% 13% 428
3 SERIOUS GASTROINTESTINAL COMPLICATIONS 163 76% 3% 114
4 ROFECOXIB 132 31% 10% 349
5 ULCER COMPLICATIONS 93 78% 2% 61
6 THERAPEUTIC ARTHRITIS RESEARCH 61 58% 2% 69
7 CYCLO OXYGENASE 2 INHIBITORS 56 24% 6% 202
8 NONSELECTIVE NSAIDS 55 87% 1% 27
9 CELECOXIB 53 16% 9% 294
10 INDUCED GASTRIC ULCER 50 58% 2% 57

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2006 527 36 97%
Guidelines for Prevention of NSAID-Related Ulcer Complications 2009 187 94 87%
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities 2006 523 94 54%
Individual NSAIDs and Upper Gastrointestinal Complications A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project) 2012 29 67 91%
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity 2012 35 84 77%
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs 1999 1155 87 62%
Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies 2014 9 65 75%
Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. 2001 848 83 36%
Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents 2008 69 39 90%
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention 2010 49 83 83%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 OFF CLIN TRAINING 7 53% 0.3% 9
2 SERV DIGEST DIS 2 14% 0.4% 15
3 IIS ARAGONCIBEREHD 2 67% 0.1% 2
4 PATIENT HLTH 2 67% 0.1% 2
5 UNITE STAT PL 2 67% 0.1% 2
6 UNIV HOSP LOZANO BLESA 1 38% 0.1% 3
7 EUPENN GRP INVESTIGATORS 1 100% 0.1% 2
8 INVEST CLIN PLURITHEMAT 803 1 50% 0.1% 2
9 MED AFFAIRS HLTH OUTCOMES 1 50% 0.1% 2
10 MED RHEUMATOL METAB BONE DIS 1 50% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000154328 DIAPHRAGM DISEASE//SMALL INTESTINAL INJURY//SMALL INTESTINAL DAMAGE
2 0.0000141689 NABUMETONE//6 METHOXY 2 NAPHTHYLACETIC ACID//6MNA
3 0.0000112614 ETODOLAC//CAS 41340 25 4//DEXTRAN CARRIER
4 0.0000097682 NIMESULIDE//CAS 51803 78 2//AULINR
5 0.0000091663 ACT STUDY//ASPIRIN DOSE//ANTIOXIDANT DEFENSE MECHANISM
6 0.0000088200 DICLOFENAC EPOLAMINE//DICLOFENAC SALTS//TOPICAL DICLOFENAC
7 0.0000084703 GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//SERV 151 E
8 0.0000083111 ENPROSTIL//E2 PROSTAGLANDINS//NOCLOPROST
9 0.0000082723 PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC
10 0.0000074011 IDIOPATHIC PEPTIC ULCER//DUODENAL PEPTIC ULCER//ATTITUDE TO THE DISEASE